Table 3

NK-cell receptor expression in p110γ- or p110δ-deficient mice

B6B6.P110g0B10D2B10D2.P110d0
Ly49CI 42.6 ± 10.3 34.0 ± 11.9 53.5 ± 5.8 56.3 ± 7.0 
Ly49D 52.5 ± 5.8 52.2 ± 3.6 40.5 ± 5.3 48.8 ± 8.1 
Ly49G2 34.7 ± 3.3 42.2 ± 12.2 48.1 ± 6.2 32.7 ± 4.3** 
Ly49CFHI 77.9 ± 2.5 67.4 ± 3.4** 86.4 ± 1.9 75.1 ± 13.1 
NKG2ACE 55.1 ± 3.1 63.1 ± 4.5* 44.3 ± 2.8 44.2 ± 0.4 
NKG2D 80.56 ± 13.0 83.26 ± 12.1 80.5 ± 9.6 86.8 ± 5.5 
B6B6.P110g0B10D2B10D2.P110d0
Ly49CI 42.6 ± 10.3 34.0 ± 11.9 53.5 ± 5.8 56.3 ± 7.0 
Ly49D 52.5 ± 5.8 52.2 ± 3.6 40.5 ± 5.3 48.8 ± 8.1 
Ly49G2 34.7 ± 3.3 42.2 ± 12.2 48.1 ± 6.2 32.7 ± 4.3** 
Ly49CFHI 77.9 ± 2.5 67.4 ± 3.4** 86.4 ± 1.9 75.1 ± 13.1 
NKG2ACE 55.1 ± 3.1 63.1 ± 4.5* 44.3 ± 2.8 44.2 ± 0.4 
NKG2D 80.56 ± 13.0 83.26 ± 12.1 80.5 ± 9.6 86.8 ± 5.5 

Mean values (%) plus or minus SD of the indicated subsets of splenic NK1.1+ CD3 NK cells. Five mice/group for B6 and B6.P110g0 and 4 mice/group for B10D2 and B10D2.P110d0 were analyzed. P values less than .05 are not shown.

*

P < .05.

**

P < .01.

Close Modal

or Create an Account

Close Modal
Close Modal